Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity Post author: Post published:February 15, 2024 Post category:uncategorized Researchers evaluated rational combination treatment regimens for advanced/metastatic non-small-cell lung cancer (NSCLC). You Might Also Like DeepPBS: A geometric AI model for accurate prediction of protein-DNA binding specificity August 9, 2024 Comprehensive database reveals protein changes associated with aging November 17, 2024 Mechanisms of tissue shape transformation revealed through fruit fly wing development August 9, 2024
DeepPBS: A geometric AI model for accurate prediction of protein-DNA binding specificity August 9, 2024